These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14353)

  • 1. Changes in dopamine synthesis rate in the supersensitivity phase after treatment with a single dose of neuroleptics.
    Hyttel J
    Psychopharmacology (Berl); 1977 Jan; 51(2):205-7. PubMed ID: 14353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence for increased dopamine receptor binding in superresponsive mice after a single dose of neuroleptics.
    Hyttel J
    Adv Biochem Psychopharmacol; 1980; 24():167-73. PubMed ID: 6105773
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for an inhibitory presynaptic component of neuroleptic drug action.
    de Belleroche JS; Bradford HF
    Br J Pharmacol; 1981 Mar; 72(3):427-33. PubMed ID: 6114766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D-1 and D-2 receptors.
    Hyttel J; Christensen AV
    J Neural Transm Suppl; 1983; 18():157-64. PubMed ID: 6135740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine autoreceptor and postsynaptic receptor blocking potency of neuroleptics.
    Kendler KS; Bracha HS; Davis KL
    Eur J Pharmacol; 1982 Apr; 79(3-4):217-23. PubMed ID: 6124428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical parameters in the hyperresponsive phase after a single dose of neuroleptics to mice.
    Hyttel J
    J Neurochem; 1979 Sep; 33(3):641-6. PubMed ID: 39118
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic treatment with five different neuroleptics elicits behavioral supersensitivity to opiate infusion into the nucleus accumbens.
    Stinus L; Nadaud D; Jauregui J; Kelley AE
    Biol Psychiatry; 1986 Jan; 21(1):34-48. PubMed ID: 2867790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of dopamine synthesis in rat striatal minces: evidence of dopamine autoreceptor supersensitivity to S(+)- but not R(-)-N-n-propylnorapomorphine after pretreatment with fluphenazine.
    Booth RG; Baldessarini RJ; Campbell A
    Biochem Pharmacol; 1991 Jun; 41(12):2040-3. PubMed ID: 1674873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The actions of antipsychotic drugs on dopamine receptors in the rat substantia nigra.
    Pinnock RD
    Br J Pharmacol; 1984 Apr; 81(4):631-5. PubMed ID: 6144343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of a strong influence of neuroleptic decanoates on dopaminergic and GABAergic functions.
    Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(2):99-107. PubMed ID: 8688897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptics, dopamine, and schizophrenia.
    Pickar D
    Psychiatr Clin North Am; 1986 Mar; 9(1):35-48. PubMed ID: 2870480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
    Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of neuroleptic drugs on drinking induced by central administration of angiotensin or carbachol.
    Sumners C; Woodruff GN; Poat JA; Munday KA
    Psychopharmacology (Berl); 1979 Feb; 60(3):291-4. PubMed ID: 35805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neuroleptics on 3H-haloperidol and 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro.
    Hyttel J
    Life Sci; 1978 Aug; 23(6):551-5. PubMed ID: 29194
    [No Abstract]   [Full Text] [Related]  

  • 16. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
    Argiolas A; Fadda F; Melis MR; Marcou M; Porceddu ML; Gessa GL
    Eur J Pharmacol; 1982 Nov; 85(1):23-7. PubMed ID: 6818043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.
    Saller CF; Salama AI
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):125-32. PubMed ID: 2878374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain].
    Matsubara R
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):570-82. PubMed ID: 7687976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of piflutixol on turnover of catecholamines in mouse brain and rat corpus striatum.
    Hyttel J
    Acta Pharmacol Toxicol (Copenh); 1977 Nov; 41(5):449-57. PubMed ID: 579556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neuroleptics on release of 3H-dopamine from slices of rat corpus striatum.
    Dismukes K; Mulder AH
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):23-9. PubMed ID: 16224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.